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http:WHAT THIS PAPER ADDS
This is the ﬁrst publication speciﬁcally analyzing the outcome of untreated primary type-Ia endoleaks. In patients
with adequate anatomy planning and execution, most will seal spontaneously and not recur, which is novel
insight into the natural history of this type of complication. Study limitations do not allow for strong recom-
mendations, but suggest a role for conservative management of self-limiting primary type-Ia endoleaks in
selected cases.Objective: Direct additional therapy is advised for type-Ia endoleaks detected on completion angiography after
endovascular aneurysm repair (EVAR). Additional intraoperative endovascular procedures are, however, often
challenging or not possible, and direct open conversion is unattractive. The results of a selective, conservative
strategy for patients with primary type-Ia endoleak has been analysed.
Methods: This was a retrospective, single-centre study (UMC, Utrecht, NL). From 2004 to 2008, all patients with a
primary type-Ia endoleak and suitable anatomy for EVAR, stentgraft oversizing 15%, and optimal deployment
were included. Complications during follow-up were studied and all sequential CTA scans were reviewed. These
were compared with the remaining patients, treated during the same period.
Results: Fifteen patients were included (14 male, median age 77, range 67e85) with a median aneurysm
diameter of 60 mm (48e80), an aneurysm neck diameter of 26 mm (21e32), a neck length of 29 mm (11e39),
and infrarenal angulation of 49 (31e90). One patient suffered rupture 2 days after EVAR e leading to the only
AAA-related death. Eight of the 15 type-Ia endoleaks disappeared spontaneously on the ﬁrst postoperative CTA,
obtained within 1 week of EVAR. On the second postoperative CTA, obtained a median of 5 months (1e12) after
EVAR, all remaining endoleaks had sealed. One recurrence occurred at 4.85 years. During a median follow-up of
3.3 years, there were ﬁve secondary interventions. Compared with controls, there were more secondary (or
recurrent) type-1a endoleaks (13% vs. 4%), endograft migrations (13% vs. 3%), sac growths (33% vs. 16%), and
secondary interventions (33% vs. 23%). None of these differences however, were statistically signiﬁcant.
Conclusions: All but one of the primary type-Ia endoleaks sealed spontaneously. Until sealing, the risk of rupture
persisted, but subsequently only one recurrence of type-Ia endoleak was seen. In selected patients, a
conservative approach for primary type-Ia endoleaks may be justiﬁed.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The aim of endovascular aneurysm repair (EVAR) is to
prevent aneurysm rupture by placement of a stentgraft,
thereby eliminating pressure on the wall of the aneurysm.1
The proximal ﬁxation and sealing of the stentgraft is often
considered the Achilles’ heel of the EVAR procedure.2
Incomplete proximal sealing results in a proximal type-1
endoleak in about 4% of all patients treated with EVAR.3erresponding author. F. Bastos Gonçalves, Erasmus University Medical
’s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
il address: f.bastosgoncalves@erasmusmc.nl (F. Bastos Gonçalves).
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//dx.doi.org/10.1016/j.ejvs.2014.01.0185 A proximal type-1 endoleak can be dangerous as high-
pressure blood ﬂow persists in the aneurysm sac.6 Pri-
mary type-1a endoleaks are proximal type-I endoleaks
visible immediately after stentgraft deployment on the
completion angiogram. Prompt treatment for these endo-
leaks is advocated, either by additional endovascular means
(ballooning or placement of a cuff or balloon expandable
stent) or by conversion to open surgery.3,7,8 Endovascular
correction of the endoleak is, however, often challenging
and even impossible in many cases, either because there is
no possibility to extend the stentgraft proximally without
compromise of renal or mesenteric vessels or because the
diameter of the neck is too large for additional (balloon
expandable) stent placement. Immediate conversion to
open surgery, on the other hand, is associated with a high
54 F. Bastos Gonçalves et al.mortality rate of up to 20e40%, although this rate has
declined over the years.9,10 Spontaneous sealing of primary
type-Ia endoleaks is also anecdotally reported, but many
believe that even spontaneously sealed type-I endoleaks
require therapy, as the chance of recurrence is unacceptably
high.11
We hypothesised that if a patient’s anatomy (speciﬁcally
neck length, diameter, tortuosity angles, and shape) is
considered suitable for EVAR, preoperative measurements
have been performed precisely (with the use of a centre
lumen line), the stentgraft is 15% oversized (using outer-
to-outer diameter measurements as reference) and the
stentgraft is deployed at the optimal position below the
lowermost renal artery, primary type-Ia endoleaks may
resolve spontaneously in most cases. Furthermore, these
type-Ia endoleaks may not recur, making additional treat-
ment unnecessary. The objective of this study was to
analyse the results of a selective conservative approach for
primary type-Ia endoleaks in patients with EVAR-suitable
anatomy and adequate stentgraft sizing and deployment.
METHODS
From August 2004 to December 2008, 285 patients un-
derwent planned endovascular aortic procedures at the
University Medical Center, Utrecht, The Netherlands. Pa-
tients treated for isolated iliac aneurysms, anastomotic or
mycotic aneurysms, non-aneurysmal disease, and those
with prior abdominal aortic surgery were excluded. This
resulted in a cohort of 216 patients. Criteria for treatment
were maximum aortic diameter greater than 55 mm, fast
growth (>5 mm in 6 months or 10 mm in 1 year), or
presence of symptoms. According to the local EVAR pro-
tocol, all AAA patients underwent preoperative imaging by
computed tomographic angiography (CTA). Preoperative
stentgraft sizing was performed, using dedicated software
with centre lumen line reconstructions (CLL) for optimal
diameter and length measurements during the entire study
period, and stentgraft oversizing of 15e20% was considered
ideal. Postoperatively, CTAs were performed within 1 week
after EVAR (typically at 48e72 hours, before discharge), and
yearly thereafter. Additional scans were performed as
indicated by the treating physician. All patient data were
entered prospectively into a dedicated database of EVAR
patients.Patient selection
A retrospective analysis of the prospective database was
performed. All patients with an intraoperative clear prox-
imal type-I endoleak after stentgraft placement and
ballooning of the sealing and overlap zones were identiﬁed
and included in the study group. The remaining patients
were included in a control group for comparison of com-
plications and secondary interventions.
Patients with a type-Ia endoleak were only left untreated
(and consequently included in this study) if the anatomy of
the neck was considered suitable for EVAR, if preoperative
stentgraft sizing was performed with the use of a CLL, if thestentgraft was correctly oversized, and if the stentgraft was
deployed at the intended, optimal position. The anatomy of
an aneurysm neck was considered suitable for EVAR if the
length was 10 mm, the diameter was 32 mm, the
infrarenal angulation was 60, and 50% of the circum-
ference consisted of thrombus or calciﬁcation. Moreover,
patients with infrarenal angulation of 60e90 were also
considered suitable if the aneurysm neck length was
15 mm.Evaluation
Age, gender, symptoms at presentation, and intraoperative
values were noted. Intraoperative values analysed were
stentgraft size and type, operation time, volume of contrast
agent used, total minutes of ﬂuoroscopy, estimated total
blood loss, administration of anticoagulants, activated
clotting time, and procedure-related problems. Further-
more, the postoperative course and possible complications
or re-interventions were investigated. All pre- and post-
operative CTA scans of included patients were transferred
to a workstation (3Mensio Medical Imaging B.V., Bilthoven,
The Netherlands) for re-evaluation.
CTA scans were performed on a 64-slice helical CT
scanner (Philips Medical Systems, Best, The Netherlands)
with a standardised acquisition protocol. Slice thickness
was 0.9 mm and radiation exposure parameters were
120 kVp and 300 mAs, resulting in a CT dose index (CTDI-
vol) of 17.6 mGy. Early and late arterial phase scans were
obtained.Measurement
Preoperative CTAs were reviewed for maximum AAA
diameter, total aneurysm volume, neck length, neck diam-
eter, supra- (a) and infrarenal (b) neck angulation, and
calciﬁcation and thrombus lining the neck. All available
postoperative CTAs were investigated for maximum AAA
diameter, total aneurysm volume, the presence of endo-
leaks, and stentgraft migration.
All measurements were performed using CLL re-
constructions. Volume and angle measurements were per-
formed according to earlier published protocols.12,13 The
neck diameter was measured 1 cm caudal to the lowermost
renal artery. The presence of calciﬁcation and thrombus in
the aneurysm neck were also visually quantiﬁed at this
level. Stentgraft migration was deﬁned as a migration of the
most proximal stentgraft ring of 10 mm according to the
reporting standards for EVAR.1Endpoints
The primary endpoint was persistent sealing of the type-Ia
endoleak. Secondary endpoints were freedom from; sec-
ondary intervention, secondary type-Ia endoleak, migration,
post-implantation sac growth, AAA-related death, and all-
cause death.
Table 1. Baseline characteristics.
Variable Study group
(N ¼ 15)
Control group
(N ¼ 201)
p
Age e median (range) 76 (67e85) 74 (47e89) .086
Male gender e N (%) 14 (93) 180 (90) 1.0
ASA III/IV e N (%) 9 (60) 116 (58) 1.0
Endograft model .01
Talent bif, N (%) 13 (86) 115 (57)
Talent AUI, N (%) 1 (7) 7 (3)
Zenith, N (%) 1 (7) 2 (1)
Excluder, N (%) e 43 (21)
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Baseline characteristics were described as counts and per-
centages (dichotomous variables), or medians and range
(continuous variables). Differences were assessed using
Fisher’s exact test or ManneWhitney U test, as indicated.
Differences in endograft model were tested with Person’s
chi-square test. All tests were two-sided and signiﬁcance
was considered when p < 0.05. Statistical analysis was
performed using the IBM SPSS Statistics 20 (IBM Inc., Chi-
cago, IL, USA).Endurant, N (%) e 34 (17)
Bif ¼ bifurcated; AUI ¼ aorto-uni-iliac.
RESULTS
Fifteen patients with a primary type-Ia endoleak met the
inclusion criteria (14 male, median age 77, range 67e85,
6.9% of all EVAR patients, Table 1). Fourteen patients were
asymptomatic at presentation, and one patient presented
with a symptomatic intact AAA (case 10). The preoperative
median aneurysm diameter was 60 mm (48e80) and the
aneurysm sac volume was 217 mL (116e552) (Table 2). The
median neck diameter was 26 mm (21e32) and neck length
29 mm (11e39). The suprarenal angle (a) was 31 (13e82)
and the infrarenal angle (b) was 49 (31e90). During the
study period, there were no direct conversions to open
repair and one patient received an aortic cuff to treat a
type-Ia endoleak caused by low-deployment. No primary
type-Ia endoleaks were left untreated in the control group.
Thirteen patients were treated with a Talent bifurcated
stentgraft (Medtronic, Minneapolis, MN, USA), one with
both a Talent bifurcated and a Talent aorto-uni-iliac device
and one patient with a Zenith bifurcated stentgraft (Cook,
Bloomington, IN, USA). Signiﬁcant differences were
observed in the type of grafts used in the study and control
groups, where the distribution of types of graft was greater
(Table 1). The median stentgraft oversizing was 21% (10e
31) and eight patients (53%) were treated with an endograft
sized 32 mm proximally. Patient 11 had an hourglass neck
39 mm in length, and oversizing was 15e20% in the mid-
section, despite a 10% oversizing only in the proximal
10 mm.Table 2. Preoperative aneurysm neck morphology (study group).
Pt AAA B (mm) a angle () b angle () Neck length (mm) N
1 64 44 67 17 0
2 48 43 90 31 0
3 80 20 59 12 0
4 60 36 35 29 0
5 64 16 50 11 2
6 65 16 31 30 <
7 69 82 81 16 <
8 60 34 31 16 0
9 58 13 39 32 0
10 74 27 49 34 0
11 55 23 31 39 <
12 60 31 39 18 <
13 52 32 65 30 0
14 54 13 34 32 <
15 69 65 70 15 <
Pt ¼ patient; B ¼ diameter; a ¼ suprarenal; b ¼ infrarenal; calcif ¼All patients received 5000 units of heparin just before
catheterisation. The activated clotting time (ACT) was
maintained 2 times normal during all procedures. Sten-
tgraft deployment was successful and uncomplicated in 14
patients. In one patient a bifurcated stentgraft was inad-
vertently deployed 2 cm below the intended position (case
number 7). An aorto-uni-iliac stentgraft was subsequently
placed through the bifurcated stentgraft at the intended
proximal position, followed by a contralateral iliac occluder
and a femoro-femoral crossover bypass. As the second
stentgraft was placed at the optimal position, this patient
was still included in the study group. Blood loss was
<150 cc during all EVAR procedures and the median
operation time was 120 minutes (80e173). Median contrast
volume used was 110 mL (70e170), and median ﬂuoros-
copy time (in half-dose setting) was 20 minutes (8e43). All
15 patients had a clear, unmistakable, proximal type-I
endoleak at the completion angiogram, which was veriﬁed
by two of three vascular surgeons with extensive experi-
ence in EVAR (HV, FM or JvH) (Fig. 1).
In all patients a CTA was obtained within 1 week of EVAR,
and all had a minimum of 1 yearly CTA during postoperative
surveillance. The type-Ia endoleak had disappeared spon-
taneously on the ﬁrst postoperative CTA in 8 of the 15
patients (Table 3). In the other seven patients, a clear type-
Ia endoleak was still seen. In one of these patients theeck calcif (%) Neck thromb (%) Neck B (mm) MB B (mm)
<25 25 28
<25 21 26
0 28 34
0 26 32
5e50 0 21 26
25 25e50 28 34
25 0 28 32
0 21 26
<25 29 34
0 25 30
25 25e50 32 36
25 <25 27 32
<25 26 30
25 25e50 28 32
25 25e50 26 30
calciﬁcation; thromb ¼ thrombus; MB ¼ main body.
Figure 1. Examples of intraoperative type-Ia endoleaks managed conservatively. Arrow indicates the type-Ia endoleak.
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treatment was possible (case 7). This patient had lumbar
pain and hypotension, which led to a CTA investigation 48
hours postoperatively, where a large type-Ia endoleak and a
posterior retroperitoneal rupture were evident. On the
second postoperative CTA, obtained a median of 5 months
(1e12) after EVAR, no more type-Ia endoleaks were seen.
An unmistakable recurrence of a type-Ia endoleak was
observed in one patient (case 9), 4.85 years after EVAR
(Table 4). This was associated with dilatation of the proximal
neck beyond the diameter of the implanted endograft. At this
time, the previously stable aneurysm sac exhibited growth,
and the patient was successfully converted to open repair. In
a second patient, sac growthwas noted 1.85 years after EVAR
(case 13). As a result of neck dilatation and proximal migra-
tion (<10 mm) in a previously angulated neck (65 preop-
eratively), a proximal endoleak was not imaged, but was
suspected because of the short proximal seal. This patient
underwent successful implantation of a proximal extension
cuff. No other recurrences were observed.
After discharge, the median follow-up was 3.27 years
(range 0.58e5.52). During this period, ﬁve patients had
secondary interventions (Table 4). Cases 9 and 13 were for
recurrent type-Ia endoleak (case 9) and insufﬁcient proximal
ﬁxation and sealing without endoleak (case 13) and have
been described above. One patient underwent secondary
intervention after 2 years for an aneurysm diameter growth
of 16 mm (volume increase of 136 mL in combination with
an aortic neck dilation of 8 mm) in the absence of an
endoleak (case 1). Conversion to open repair was per-
formed without further complications. During the conver-
sion procedure, there was no visible endoleak when
opening the aneurysm sac. One other patient underwent
implantation of a proximal extension cuff 1.25 years after
EVAR for stentgraft migration of 10 mm. This was probably
caused by a neck dilation of 5 mm (case 10). Stentgraft
migration occurred in one other patient after 1.85 years
(case12). This was successfully treated by implantation of an
aorto-uni-iliac device.
Six patients died during follow-up (Table 3): one as a
result of a ruptured aneurysm 2 days after EVAR; three fromcancer; one from infection; and one the cause for which
could not be determined (Table 3). No other AAA-related
deaths occurred in the study group.
In comparison with the control group, patients included in
the study group had shorter follow-up time, and shorter time
to ﬁrst intervention, although these differences were not
statistically signiﬁcant (Table 5). There was a greater pro-
portion of patients suffering from secondary (or recurrent)
type-Ia endoleak (13% vs. 4%), endograft migration (13% vs.
3%), and sac growth (33% vs. 16%). Similarly, a greater pro-
portion required secondary intervention (33% vs. 23%) and
particularly conversion to open repair (13% vs. 5%). None of
these differences however, was statistically signiﬁcant.DISCUSSION
In this study, the conservative management of primary
type-1a endoleaks in patients with adequate anatomy,
planning, and implantation led to spontaneous resolution in
most cases. A watchful attitude towards primary type-1a
endoleaks in selected patients may be preferable to im-
mediate conversion or complex endovascular techniques.
However, our data suggest an increased risk of late com-
plications and secondary interventions that must be
factored into the decision of whether to observe or
intervene.
The natural history of an untreated type-1a endoleak
remains undetermined. Although common sense suggests
that rupture risk is the same as the risk of an untreated AAA
of similar diameter, Venermo et al. suggest that EVAR offers
protection from rupture despite the presence of sac pres-
surisation.14 These authors suggest that growth, rather than
the presence of endoleak, is a better predictor of rupture
after EVAR. In their series of 21 patients with untreated
type-Ia endoleak, only one rupture occurred (2.5 years after
EVAR) after a 2 cm enlargement. In this study, one rupture
occurred 2 days after EVAR. The cause for this cannot be
fully explained. An iatrogenic lesion of the aneurysm wall
cannot be ruled out, as the procedure was complex and the
temporal relationship between implant and rupture is
unusual.
Table 3. Outcome of patients after conservative management of primary type-Ia endoleaks.
Pt Sp. seal (d) Rec 1aEL (y) Migration (y) Sac growth (y) AAA rupt (y) Total FU (y) Death (y) Death cause
1 Y (51) N N Y (1.96) N 5.52 N e
2 Y (2) N N N N 5.51 Y (5.51) Cancer
3 Y (112) N N N N 4.71 Y (4.71) Cancer
4 Y (2) N N N N 4.05 N e
5 Y (370) N N Y (1.99) N 3.56 N e
6 Y (134) N N N N 2.02 N e
7 N N N N Y (0.01) 0.01 Y (0.01) Early rupture
8 Y (3) N N N N 0.58 Y (0.58) Undetermined
9 Y (147) Y (4.85) N Y (4.85) N 5.31 N N
10 Y (4) N Y (1.25) N N 2.29 N N
11 Y (2) N N N N 2.07 Y (2.07) Infection
12 Y (2) N Y (1.85) N N 4.07 N N
13 Y (2) ? (2.05) N Y (2.05) N 2.97 N N
14 Y (2) N N N N 2.17 Y (2.17) Cancer
15 Y (238) N N Y (1.65) N 1.67 N N
d ¼ days; FU ¼ follow-up; Pt ¼ patient; Rec 1aEL ¼ recurrent type-Ia endoleak; rupt ¼ rupture; Sp. ¼ spontaneous; y ¼ years; ? ¼
unconﬁrmed.
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and executed cases is most likely to be multifactorial.
Coagulation abnormalities (antiplatelet þ intraoperative
anticoagulation with ACT >2), morphological aspects of the
neck (shape, angulation, irregularities caused by thrombus
or plaques), and structural characteristics of the endograft
may contribute to varying degrees. The spontaneous
disappearance of type-1a endoleaks after appropriate
stentgraft sizing and deployment in this speciﬁc patient
group is not surprising, once the coagulation abnormalities
are (at least partially) corrected and the self-expanding
nature of the stentgrafts leads to gradual neck remodel-
ling and improved graft-wall apposition. Late-resolution
endoleaks (beyond 1 week) occurred in patients who
were either chronically anticoagulated (cases 5 and 15), had
angulated and relatively short necks (cases 1 and 3), or had
an irregular wall due to thrombus (case 6) (Table 2).
Anecdotal reports have suggested a high chance of
recurrence after sealing of primary type-1a endoleaks has
occurred.5,15,16 Only one recurrence was detected after 5
years, probably caused by progression of disease. It is
believed that this low recurrence rate is directly associated
with the criteria for watchful waiting. Data suggest, how-
ever, that patients with spontaneously sealed proximal
endoleaks are at high risk of complications and more likelyTable 4. Secondary interventions after conservative management
of primary type-Ia endoleaks.
Pt Sec. interv. (y) Cause for sec. interv. Type of sec. interv
1 Y (1.96) Sac growth without
visible EL
Conversion to open
7 Y (0.01) Rupture Conversion to open
9 Y (4.85) Proximal type-Ia EL Conversion to open
10 Y (1.25) Migration without
visible EL
Proximal extension
12 Y (1.85) Migration without
visible EL
Conversion to AUI
13 Y (2.05) Sac growth without
visible EL
Proximal extension
Sec. interv ¼ secondary intervention; y ¼ years.to require secondary interventions. Therefore, particular
attention to image surveillance and a low threshold for
intervention is advisable, especially for endoleaks persisting
beyond 1 week. The subgroup of patients with angulation
60e90 appeared to be at higher risk of complications
(Tables 2 and 3), but the contribution of the previously
existing type-Ia endoleak is not dissociable from the higher
risk resulting from less favourable anatomy alone.
When a device is placed at the intended position just
below the lowermost renal artery and a type-1a endoleak
persists despite re-ballooning, alternatives to immediate
conversion or vigilance are scarce. Placement of a proximal
extension cuff is redundant, and (balloon expandable) stent
placement (such as “giant” Palmaz stent [Cordis Corp,
Miami Flakes, FL, USA]) is limited by maximum diameter
and complexity.15 The Chimney technique potentially allows
the resolution of type-1a endoleaks with reasonable results
in the mid-term17,18 and endostaples (Aptus Endosystems,
Sunnyvale, CA, USA) are also available, and may be used to
enhance proximal ﬁxation and seal. Early experience with
this technology suggests high technical success rates and
promising results, but the durability of this adjunct remains
unknown.19 Off-the-shelf fenestrated or branched devices
have recently been marketed or are under development by
most major manufacturers, and may provide a better so-
lution in patients with appropriate anatomy.Limitations
Firstly, the study sample is small and consequently the
number of events for individual endpoint analysis is
restricted. The absence of statistical signiﬁcance between
the study and control groups should be interpreted as a
likely type-1 statistical error, and not as proof of equiva-
lence. Also, the majority of patients were treated with the
Talent endograft, which is stiffer and has less efﬁcient ﬁx-
ation than most modern alternatives. In these patients, AAA
neck conﬁguration was not evaluated, and could help
explain the occurrence of primary type-Ia endoleaks in
Table 5. Comparison between patients after conservative management of primary type-Ia endoleaks and the remaining EVAR-treated
population.
Variable Study group (N ¼ 14)a Control group (N ¼ 201) p
Total FU (y), median (range) 3.27 (0.58e5.52) 3.93 (0.09e8.88) .652
Time to ﬁrst complic., median (range) 2.03 (0.58e5.51) 2.92 (0.00e8.88) .824
Type-Ia endoleak during FU, N (%) 1 (7) 8 (4) .843
Migration, N (%) 2 (13) 5 (3) .078
Conversion to open repair, N (%) 2 (13) 9 (5) .172
Post-implant rupture, N (%) 1 (7) 1 (0.5) .134
Sac growth, N (%) 5 (33) 32 (16) .145
Secondary intervention, N (%) 5 (33) 46 (23) .354
y ¼ years.
a Only considering discharged patients.
58 F. Bastos Gonçalves et al.otherwise favourable conditions. Lastly, the exact propor-
tion of patients treated successfully with re-ballooning of
the proximal attachment site could not be determined.
Conclusion
All but one of the primary type-1a endoleaks after EVAR in
this speciﬁc 15 patient group sealed spontaneously and only
one clear recurrence was observed, after 5 years. Although
the data suggest that these patients may be at higher risk of
complications and may require more secondary in-
terventions, a conservative approach may be justiﬁed under
strict circumstances, especially when endovascular options
are not feasible and direct conversion to open repair is
considered high-risk. Future off-the-shelf devices allowing
for extension of the proximal sealing zone may present a
more durable and elegant solution.
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